Core Scientific, Inc.CORZNASDAQ
Loading
EBITDA as a percentage of revenue
Percentile
P33
Within normal range
vs 5Y Ago
-8.8x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -23.76% | +89.5% |
| 2024 | -226.56% | -1703.2% |
| 2023 | -12.56% | +95.6% |
| 2022 | -287.44% | -1211.6% |
| 2021 | 25.86% | +855.1% |
| 2020 | 2.71% | +128.9% |
| 2019 | -9.36% | - |